RARβ has been shown to be associated with thyroid cancer recurrence; however, in our meta-analysis, it was not possible to examine this concept by subgroup analyses due to the low sample size and lack of data related to recurrence in the identified studies. Here, RARB is linked to thyroid gland carcinoma.